PARSIPPANY, N.J., May 3, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), today announced that the Company will host its 2013 Annual Meeting of Stockholders on Friday, May 10, 2013 beginning at 8:30 AM Eastern Daylight Time. The meeting will be held at the Parsippany Sheraton in Parsippany, NJ, and will be open to in-person stockholders of record only.
Actavis will not be providing a formal update on the business at the meeting, but rather will consider and vote on certain routine matters, including the election of certain directors, the ratification of the appointment of the Company's independent registered public accounting firm and other Company business as more fully described in its Notice of Annual Meeting and proxy statement.
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global headquarters in Parsippany, New Jersey, USA.
Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries. Actavis Specialty Brands is the Company's global branded specialty pharmaceutical business, focused in the Urology and Women's Health therapeutic categories. Actavis Specialty Brands also has a portfolio of 5 biosimilar products in development in Women's Health and Oncology. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., the fourth-largest U.S. generic pharmaceutical product distributor in the United States.
For press release and other company information, visit Actavis' Web site at http://www.actavis.com.
(Logo: http://photos.prnewswire.com/prnh/20130124/NY47381LOGO )
SOURCE Actavis, Inc.
Help employers find you! Check out all the jobs and post your resume.